FDA Seeks Input On Generics Law, But Not On Declaratory Judgments
This article was originally published in The Pink Sheet Daily
Executive Summary
Comments will be considered as agency starts to develop regulations implementing changes made by the Medicare Rx law. FDA will not write lawsuit process rules, Chief Counsel Troy tells GPhA.